Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice
Authors
Keywords
T cells, Vaccines, Cytotoxic T cells, Enzyme-linked immunoassays, Immune response, HIV, HIV-1, HIV vaccines
Journal
PLoS One
Volume 8, Issue 8, Pages e71601
Publisher
Public Library of Science (PLoS)
Online
2013-08-21
DOI
10.1371/journal.pone.0071601
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathogen Proliferation Governs the Magnitude but Compromises the Function of CD8 T Cells
- (2014) Subash Sad et al. JOURNAL OF IMMUNOLOGY
- Robust Immunity to an Auxotrophic Mycobacterium bovis BCG-VLP Prime-Boost HIV Vaccine Candidate in a Nonhuman Primate Model
- (2013) G. K. Chege et al. JOURNAL OF VIROLOGY
- Identifying Predictors of Interferon-γ Release Assay Results in Pediatric Latent Tuberculosis: A Protective Role of Bacillus Calmette-Guérin?
- (2012) Robindra Basu Roy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Differential Gag-Specific Polyfunctional T Cell Maturation Patterns in HIV-1 Elite Controllers
- (2012) S. Ferrando-Martinez et al. JOURNAL OF VIROLOGY
- Elite Controllers with Low to Absent Effector CD8+ T Cell Responses Maintain Highly Functional, Broadly Directed Central Memory Responses
- (2012) Z. M. Ndhlovu et al. JOURNAL OF VIROLOGY
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8+ T Cells
- (2012) Rosamund Chapman et al. PLoS One
- Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors
- (2011) Richard Hopkins et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Dual Neonate Vaccine Platform against HIV-1 and M. tuberculosis
- (2011) Richard Hopkins et al. PLoS One
- Molecular Characterization of Heterologous HIV-1gp120 Gene Expression Disruption inMycobacterium bovisBCG Host Strain: A Critical Issue for Engineering Mycobacterial Based-Vaccine Vectors
- (2010) Joan Joseph et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Novel Recombinant Mycobacterium bovis BCG, Ovine Atadenovirus, and Modified Vaccinia Virus Ankara Vaccines Combine To Induce Robust Human Immunodeficiency Virus-Specific CD4 and CD8 T-Cell Responses in Rhesus Macaques
- (2010) M. Rosario et al. JOURNAL OF VIROLOGY
- IFN- Expressed by T Cells Regulates the Persistence of Antigen Presentation by Limiting the Survival of Dendritic Cells
- (2009) M. S. Russell et al. JOURNAL OF IMMUNOLOGY
- Recombinant Mycobacterium bovis BCG Prime-Recombinant Adenovirus Boost Vaccination in Rhesus Monkeys Elicits Robust Polyfunctional Simian Immunodeficiency Virus-Specific T-Cell Responses
- (2009) M. J. Cayabyab et al. JOURNAL OF VIROLOGY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay
- (2009) Michael Eisenhut et al. VACCINE
- A Multigene HIV Type 1 Subtype C Modified Vaccinia Ankara (MVA) Vaccine Efficiently Boosts Immune Responses to a DNA Vaccine in Mice
- (2008) Enid Shephard et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- A Replication-Limited Recombinant Mycobacterium bovis BCG Vaccine against Tuberculosis Designed for Human Immunodeficiency Virus-Positive Persons Is Safer and More Efficacious than BCG
- (2008) M. V. Tullius et al. INFECTION AND IMMUNITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More